Clinical Trials on Lung Fibrosis in New Zealand
Total 6978 results
-
InSilico Medicine Hong Kong LimitedCompletedA Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy SubjectsIdiopathic Pulmonary FibrosisNew Zealand
-
Arrowhead PharmaceuticalsRecruitingIdiopathic Pulmonary FibrosisDenmark, New Zealand, Spain
-
ReCode TherapeuticsRecruitingCystic FibrosisNew Zealand
-
Arcturus Therapeutics, Inc.Novotech CRORecruiting
-
Algernon PharmaceuticalsCompletedIdiopathic Pulmonary FibrosisAustralia, New Zealand
-
Cystetic Medicines, Inc.DevPro BiopharmaRecruitingCystic FibrosisAustralia, New Zealand
-
Biosplice Therapeutics, Inc.WithdrawnIdiopathic Pulmonary FibrosisAustralia, New Zealand
-
Arrowhead PharmaceuticalsTerminatedCystic Fibrosis, PulmonaryAustralia, New Zealand
-
PharmaxisCompletedCystic FibrosisAustralia, New Zealand
-
The University of QueenslandTelethon Kids InstituteCompletedBronchiectasis | Cystic FibrosisAustralia, New Zealand
-
Pliant Therapeutics, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States, Belgium, Australia, Netherlands, Canada, Italy, New Zealand
-
Middlemore Hospital, New ZealandUnknown
-
Lassen Therapeutics 1 PTY LTDRecruitingThyroid Eye Disease | Pulmonary FibrosisAustralia, New Zealand, Hong Kong
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
National Jewish HealthYale University; Icahn School of Medicine at Mount Sinai; AstraZeneca; Baylor University and other collaboratorsActive, not recruitingIdiopathic Pulmonary Fibrosis (IPF)United States
-
Chinese University of Hong KongRecruiting
-
University of Auckland, New ZealandTerminatedSmoking Cessation | Chronic Obstructive Pulmonary DiseaseNew Zealand
-
University of OtagoCompleted
-
Mylan Inc.Theravance BiopharmaCompleted
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease, COPDNew Zealand
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI); University of Iowa; Weill... and other collaboratorsCompletedIdiopathic Pulmonary Fibrosis | Interstitial Lung DiseaseUnited States
-
FibroGenCompletedIdiopathic Pulmonary FibrosisUnited States, New Zealand, India, South Africa, Australia, Bulgaria, Canada
-
Waikato HospitalWaikato Hospital Research FundCompletedChronic Obstructive Pulmonary DiseaseNew Zealand
-
GlaxoSmithKlineCompleted
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedIdiopathic Pulmonary Fibrosis | Interstitial Lung Disease | Diffuse Parenchymal Lung DiseaseUnited States
-
GlaxoSmithKlineCompleted
-
NYU Langone HealthStony Brook University; National Center for Research Resources (NCRR); Philips...CompletedPulmonary FibrosisUnited States
-
NYU Langone HealthWithdrawnIdiopathic Pulmonary FibrosisUnited States
-
Bristol-Myers SquibbCompletedHealthy Participants | Idiopathic Pulmonary Fibrosis (IPF)United States
-
HuniLife Biotechnology, Inc.RecruitingIdiopathic Pulmonary FibrosisTaiwan
-
Columbia UniversityGenentech, Inc.Recruiting
-
Akesobio Australia Pty LtdCompletedCoronavirus Disease 2019 (COVID-19)New Zealand
-
Hal ChapmanMassachusetts General Hospital; University of Michigan; University of Washington and other collaboratorsRecruitingIdiopathic Pulmonary FibrosisUnited States
-
University of OtagoHealth Research Council, New ZealandCompleted
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI); University of Chicago; Columbia... and other collaboratorsCompletedIdiopathic Pulmonary FibrosisUnited States
-
FibroGenCompletedIdiopathic Pulmonary FibrosisUnited States
-
Restorbio Inc.CompletedRespiratory Tract InfectionsNew Zealand
-
Syneos HealthUS Specialty Formulations, LLCCompletedSARS-CoV-2 (COVID-19)New Zealand
-
GlaxoSmithKlineCompleted
-
Jiangsu Rec-Biotechnology Co., Ltd.Iqvia Pty LtdCompleted
-
Mabwell (Shanghai) Bioscience Co., Ltd.RecruitingPulmonary Fibrosis | TumorAustralia
-
Fisher and Paykel HealthcareMedical Research Institute of New Zealand; Alana HealthcareTerminatedChronic Obstructive Pulmonary Disease | COPDUnited States, New Zealand
-
University of Alabama at BirminghamUniversity of Michigan; Tulane University; Temple UniversityRecruitingIdiopathic Pulmonary FibrosisUnited States